Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling study

dc.contributor.authorLeelahavarong P.
dc.contributor.authorPrawjaeng J.
dc.contributor.authorAngkab P.
dc.contributor.authorWongkom N.
dc.contributor.authorScheltens P.
dc.contributor.authorSrinonprasert V.
dc.contributor.authorSenanarong V.
dc.contributor.correspondenceLeelahavarong P.
dc.contributor.otherMahidol University
dc.date.accessioned2026-05-27T18:10:40Z
dc.date.available2026-05-27T18:10:40Z
dc.date.issued2026-04-02
dc.identifier.citationBMC Health Services Research Vol.26 No.1 (2026)
dc.identifier.doi10.1186/s12913-026-14405-5
dc.identifier.eissn14726963
dc.identifier.pmid41928210
dc.identifier.scopus2-s2.0-105039248136
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/116927
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleCost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling study
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105039248136&origin=inward
oaire.citation.issue1
oaire.citation.titleBMC Health Services Research
oaire.citation.volume26
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationEQT Partners Netherlands B.V.

Files

Collections